Grimes & Company’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Sell
5,951
-30
-0.5% -$2.42K 0.01% 311
2026
Q1
$423K Buy
5,981
+137
+2% +$10.3K 0.01% 318
2025
Q4
$461K Buy
5,844
+482
+9% +$38.1K 0.01% 319
2025
Q3
$442K Sell
5,362
-334
-6% -$26.3K 0.01% 324
2025
Q2
$458K Sell
5,696
-79
-1% -$6.1K 0.01% 279
2025
Q1
$464K Sell
5,775
-4,767
-45% -$396K 0.01% 247
2024
Q4
$863K Sell
10,542
-201
-2% -$16.7K 0.02% 207
2024
Q3
$886K Sell
10,743
-971
-8% -$72.5K 0.02% 193
2024
Q2
$822K Sell
11,714
-411
-3% -$29.3K 0.02% 185
2024
Q1
$899K Sell
12,125
-399
-3% -$27.8K 0.03% 187
2023
Q4
$828K Buy
12,524
+277
+2% +$17.3K 0.03% 185
2023
Q3
$770K Sell
12,247
-79,554
-87% -$4.95M 0.03% 177
2023
Q2
$5.19M Buy
91,801
+4,201
+5% +$233K 0.18% 90
2023
Q1
$5.08M Buy
87,600
+8,015
+10% +$541K 0.21% 87
2022
Q4
$5.76M Buy
79,585
+6,313
+9% +$452K 0.24% 80
2022
Q3
$4.45M Buy
73,272
+3,452
+5% +$221K 0.23% 83
2022
Q2
$4.38M Buy
69,820
+1,551
+2% +$103K 0.22% 88
2022
Q1
$4.8M Buy
68,269
+6,260
+10% +$423K 0.25% 88
2021
Q4
$3.88M Buy
62,009
+2,416
+4% +$152K 0.18% 97
2021
Q3
$3.68M Buy
59,593
+2,826
+5% +$170K 0.16% 98
2021
Q2
$3.4M Buy
56,767
+1,202
+2% +$76.2K 0.15% 98
2021
Q1
$3.38M Sell
55,565
-1,395
-2% -$77K 0.16% 98
2020
Q4
$2.67M Buy
56,960
+5,371
+10% +$233K 0.14% 103
2020
Q3
$1.92M Buy
51,589
+12,915
+33% +$490K 0.12% 103
2020
Q2
$1.41M Buy
38,674
+2,244
+6% +$78.1K 0.1% 110
2020
Q1
$1.11M Buy
+36,430
New +$1.62M 0.1% 110

Other funds holding MET

Grimes & Company's MET Position: Q2 2026 in Review

Grimes & Company reduced its MetLife (MET) stake by 0.5% in Q2 2026, selling an estimated $2.42K and leaving 5,951 shares worth $503K. The position accounts for 0.01% of the portfolio, ranked #311.

Grimes & Company first reported a position in MET in Q1 2020 and has held it in 26 quarters since. The position peaked at $5.76M in Q4 2022. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Grimes & Company held 5,951 shares of MetLife worth $503K as of Q2 2026.
  • Grimes & Company sold 30 MetLife shares in Q2 2026, an estimated $2.42K.
  • MetLife made up 0.01% of Grimes & Company's portfolio in Q2 2026, its #311 holding.
  • Grimes & Company first reported a position in MetLife in Q1 2020 and has held it in 26 quarters since.
  • Grimes & Company's MetLife position peaked at $5.76M in Q4 2022.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.